The neuromuscular and other blocking actions of 4,17a-dimethyl-4,17a-diaza-d-homo-5 -androstane dimethiodide (HS-342) in the anaesthetized cat.
D000731:Androstanes / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000758:Anesthesia; D000818:Animals; D001372:Aza Compounds / Q000037:antagonists & inhibitors / Q000494:pharmacology; D002415:Cats; D004305:Dose-Response Relationship, Drug; D004491:Edrophonium / Q000494:pharmacology; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006718:Homosteroids / Q000037:antagonists & inhibitors / Q000494:pharmacology; D066298:In Vitro Techniques; D007454:Iodides / Q000037:antagonists & inhibitors / Q000494:pharmacology; D008297:Male; D009467:Neuromuscular Depolarizing Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D013997:Time Factors; D014630:Vagus Nerve / Q000187:drug effects
D000731:Androstanes; D001372:Aza Compounds; D006718:Homosteroids; D007454:Iodides; D009467:Neuromuscular Depolarizing Agents; D004491:Edrophonium